Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-04-17 09:35 am Purchase |
2025-03-31 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
9,977,061 9.400% |
244,662 (+2.51%) |
Filing History |
| 2025-03-05 5:00 pm Unchanged |
2025-02-18 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC GILD |
39,691,649 35.000% |
0 (Unchanged) |
Filing History |
| 2025-02-20 7:43 pm Purchase |
2025-02-18 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC GILD |
39,691,649 35.000% |
8,158,868 (+25.87%) |
Filing History |
| 2024-12-17 9:52 pm Sale |
2024-10-28 | 13D | Arcus Biosciences, Inc. RCUS |
ROSEN TERRY J | 3,790,875 4.100% |
-501,865 (-11.69%) |
Filing History |
| 2024-11-12 09:50 am Sale |
2024-11-08 | 13G | Arcus Biosciences, Inc. RCUS |
FMR CORP | 4,467,557 4.886% |
-261,225 (-5.52%) |
Filing History |
| 2024-11-08 5:31 pm Unchanged |
2024-09-30 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
9,732,399 10.600% |
0 (Unchanged) |
Filing History |
| 2024-10-23 5:04 pm Sale |
2024-09-30 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
9,732,399 10.600% |
-302,771 (-3.02%) |
Filing History |
| 2024-10-17 11:31 am Sale |
2024-09-30 | 13G | Arcus Biosciences, Inc. RCUS |
STATE STREET CORP STT |
3,011,174 3.300% |
-1,228,403 (-28.97%) |
Filing History |
| 2024-02-13 4:58 pm Purchase |
2023-12-29 | 13G | Arcus Biosciences, Inc. RCUS |
The Vanguard Group | 4,680,716 6.250% |
307,539 (+7.03%) |
Filing History |
| 2024-02-09 08:35 am Purchase |
2024-02-08 | 13G | Arcus Biosciences, Inc. RCUS |
FMR CORP | 4,728,782 6.317% |
4,728,782 (New Position) |
Filing History |
| 2024-01-31 4:58 pm Purchase |
2024-01-29 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC GILD |
31,532,781 35.000% |
5,945,828 (+23.24%) |
Filing History |
| 2024-01-24 07:33 am Purchase |
2023-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
STATE STREET CORP STT |
4,239,577 5.660% |
4,239,577 (New Position) |
Filing History |
| 2024-01-23 11:52 am Purchase |
2023-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
10,035,170 13.400% |
646,122 (+6.88%) |
Filing History |
| 2023-07-06 09:38 am Purchase |
2023-06-28 | 13D | Arcus Biosciences, Inc. RCUS |
GILEAD SCIENCES INC GILD |
25,586,953 35.000% |
2,863,797 (+12.60%) |
Filing History |
| 2023-02-14 4:06 pm Sale |
2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
PFM Health Sciences, LP | 2,703,287 3.700% |
-1,229,946 (-31.27%) |
Filing History |
| 2023-02-14 11:58 am Sale |
2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
BIOTECHNOLOGY VALUE FUND L P | 2,303,520 3.200% |
-1,657,428 (-41.84%) |
Filing History |
| 2023-02-09 5:42 pm Sale |
2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
EcoR1 Capital LLC | 0 0.000% |
-5,523,358 (Position Closed) |
Filing History |
| 2023-02-09 11:07 am Purchase |
2022-12-30 | 13G | Arcus Biosciences, Inc. RCUS |
The Vanguard Group | 4,373,177 6.040% |
4,373,177 (New Position) |
Filing History |
| 2023-01-26 08:43 am Unchanged |
2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
9,389,048 13.000% |
0 (Unchanged) |
Filing History |
| 2023-01-20 09:43 am Purchase |
2022-12-31 | 13G | Arcus Biosciences, Inc. RCUS |
BLACKROCK INC BLK |
9,389,048 13.000% |
1,421,371 (+17.84%) |
Filing History |